Organogenesis (ORGO)

Last Closing Price: 2.74 (2024-05-17)

Receiveable Turnover (Annual)

Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable

Organogenesis (ORGO) had Receiveable Turnover of 5.28 for the most recently reported fiscal year, ending 2023-12-31.

Figures for fiscal year ending 2023-12-31
Income Statement Financials
$433.14M
$4.95M
$106.48M
$326.66M
$420.62M
$12.53M
$-2.13M
$10.39M
$10.39M
$4.95M
$4.95M
$4.95M
$4.95M
$12.53M
$35.97M
131.23M
132.75M
$0.04
$0.04
Balance Sheet Financials
$225.04M
$116.23M
$234.98M
$460.02M
$80.51M
$62.63M
$100.85M
$181.36M
$278.66M
$234.02M
$278.66M
131.32M
Cash Flow Statement Financials
$30.92M
$-24.36M
$-5.50M
$103.29M
$104.34M
$1.05M
$9.00M
--
--
Fundamental Metrics & Ratios
2.80
--
--
0.18
0.25
75.42%
2.89%
2.89%
8.31%
2.40%
1.14%
$6.55M
--
--
--
0.94
3.77
Receiveable Turnover
5.28
69.10
1.77%
2.11%
1.07%
1.45%
$2.12
$0.05
$0.23